Carboplatin Injections

Product/Composition:- Carboplatin Injections
Strength:- 450mg/45ml
Form:- Injection
Production Capacity 1 Million Injection/Month
Therapeutic use:- Anti Cancer
Package Insert/Leaflet: Available upon request

What is Carboplatin Injection?

Carboplatin Injection is a chemotherapy solution that is prescribed to treat different types of cancer.

It is given through an IV and is in the group of drugs that contain platinum.

It is believed to be a less nephrotoxic and neurotoxic alternative to cisplatin.

It functions just as well but has less side reactions, particularly on the nervous system and kidneys.

Overview

    Description

    Cell-killing drugs like Carboplatin are used to treat cancer.

    This is an analog of platinum from the second generation.

    It prevents cancer cells from developing and splitting by ruining their DNA.

    It was Approved by the FDA in 1989 and is now an important part of chemotherapy for many types of solid tumors.

    It is mostly used in gynecologic, thoracic, and head and neck cancer.

    Uses / Indications

    Ovarian Cancer

    Non-Small Cell and Small Cell Lung Cancer

    Head and Neck Cancers

    Endometrial Cancer

    Bladder Cancer

    Esophageal Cancer

    Benefits

    A tumor control strategy that is effective across multiple malignancies

    When compared to cisplatin, it exhibited lower levels of Nephrotoxicity and neurotoxicity

    Protocols for hydration that are simplified as a result of improved renal tolerance

    Increased bone marrow suppression that can be predicted, allowing for dose customization

    Side Effects

    How Does It Work?

    Carboplatin works by attaching to cancer cells’ DNA and creating cross-links between and within the DNA strands.

    These cross-links stop DNA from working normally, which stops replication and transcription.

    Apoptosis (planned cell death) happens in cells that are dividing quickly, like tumor cells, when DNA processes are messed with.

    Cancer cells divide faster than normal cells, which makes them more likely to be hurt by Carboplatin’s effects on DNA.

    Dosage Guidelines & How to Use

    Hospitals and oncology clinics give Carboplatin intravenously under medical supervision.

    Drug doses are tailored for each patient. The Calvert formula helps find the correct dose.

    It considers the patient’s glomerular filtration rate (GFR) and the chosen Area Under the Curve (AUC).

    This approach reduces toxicity by matching dose to renal function.

    The normal AUC target is 4–7, depending on the disease type and whether Carboplatin is taken alone or with other chemotherapeutic drugs.

    Infusions last 15–60 minutes and occur every 3–4 weeks.

    To guarantee treatment readiness, blood counts and kidney function are tested before each cycle.

    Patients with renal impairment or substantial bone marrow suppression may need dose modifications.

    Patients should follow all pre- and post-infusion guidelines.

    This includes staying hydrated and getting supportive care to ensure safety and effectiveness.

    When Not to Use

    Previous history of severe reactions to platinum drugs, including Carboplatin

    Deep depression of the bone marrow

    Currently active or untreated infection

    Acute renal failure without pharmacological modification

    Unless absolutely necessary, during pregnancy or when nursing

    Drug Interactions

    Aminoglycosides (e.g., gentamicin) – increased nephrotoxicity and Ototoxicity

    Loop diuretics (e.g., furosemide) – increased risk of auditory impairment

    Live vaccines (e.g., BCG, MMR) – diminished immune response, increased infection risk

    Additional chemotherapeutic medicines (e.g., paclitaxel, cyclophosphamide) – cumulative myelosuppression

    Nonsteroidal anti-inflammatory drugs or nephrotoxic antibiotics – increased renal risk

    Safety Advice

    Every day, complete blood count (CBC) monitoring is required.

    Prior to each cycle, it is essential to monitor renal and hepatic function.

    Be sure to drink enough water before administering the medication.

    Avoid getting pregnant, and make sure to use birth control both before and after therapy.

    General Instructions

    You should only give Carboplatin in a health institute or a center that specializes in cancer.

    Patients should do what their doctors tell them to do, including going to lab tests, staying hydrated, and keeping their meetings.

    Tell your medical professional about any rare symptoms, especially fevers, tiredness, or changes in your hearing.

    Do not try to treat yourself, and only take supportive medications as recommended, such as anti-nausea drugs.

    Special Dietary & Lifestyle Recommendations

    Take adequate hydration both before and after each session of chemotherapy.

    As a means of coping with appetite loss, consume meals that are both small and nutritious.

    Taking meals that are high in protein and iron can be healthy in reducing Fatigue.

    Avoid eating foods that are uncooked or undercooked to lower your risk of infection.

    Avoid coming into contact with sick people, and make sure you have enough rest.

    Alcohol and smoking are not allowed since they hinder the healing process and make the adverse effects much more severe.

    Comparison with Other Chemotherapy Agents

    When compared to cisplatin, Carboplatin has lower levels of Nephrotoxicity and neurotoxicity.

    This makes it a better choice, especially for older people or people with kidney problems.

    Carboplatin, on the other hand, has more effects on the bone marrow, especially thrombocytopenia.

    Oxaliplatin is used to treat colorectal cancer, but Carboplatin is used to treat a wider range of solid cancers.

    It is more likely for oxaliplatin to cause peripheral neuropathy.

    Each platinum drug is used for a different reason depending on the type of tumor, how poisonous it is, and the treatment plan.

    Precautions & Warnings

    Fertility risk: Could impact both male and female fertility

    Category D pregnancy: may be harmful to the fetus

    Breastfeeding: It is not advised while undergoing therapy.

    Warning: Older adults are more likely to experience myelosuppression.

    Can You Take It with Other Medications?

    It is possible, but only with close medical monitoring.

    This drug is often mixed with other chemotherapeutics, like

    Storage

    Vials should be kept between 20°C and 25°C (68°F and 77°F).

    Avoid freezing and shield from light.

    The drug is stable at room temperature for eight hours following dilution.

    Use only a solution that is clear and particle-free.

    Keep out of children’s reach.